🗞 Newsmakers — 3PM ET, 2026-06-04

🔥 HOT SECTORS TODAY (the sectors to watch): Technology +2.26% Communication Services +2.19% Financial Services +1.36% Industrials +1.14%

📰 MARKET THEMES & CATALYSTS: • Otsuka says kidney disease drug preserves function in late-stage study Otsuka Pharmaceutical said on Thursday its drug in a late-stage study preserved kidney function over 12 months ​in patients with a type of autoimmune disease that affects ‌the organ. — reuters.com · 06/04 2:40p https://www.reuters.com/business/healthcare-pharmaceuticals/otsuka-says-kidney-disease-drug-preserves-function-late-stage-study-2026-06-04/ • AI Bubble Is Way Bigger Than Dot-Com Valuations of upcoming tech IPOs like SpaceX, OpenAI, and Anthropic signal bubble conditions surpassing the Dot-Com era. S&P is poised to relax index inclusion rules, enabling unprofitable mega caps like SpaceX to join the S&P 500 rapidly. — seekingalpha.com · 06/04 2:11p https://seekingalpha.com/article/4912079-ai-bubble-way-bigger-than-dot-com • Options Bears Are Betting Against Industrial Stocks The Industrial Select Sector SPDR Fund (XLI) exchange-traded fund (ETF)  is up 0.9% to trade at $175.58 today. — schaeffersresearch.com · 06/04 2:00p https://www.schaeffersresearch.com/content/options/2026/06/04/options-bears-are-betting-against-industrial-stocks • An Irrational Market: 8 Charts Equity markets are in an overbought mania stage driven by the AI Revolution, with downside risk outweighing continued rally potential. Valuation metrics across the board—Shiller PE, equity risk premium, and market concentration—are at or near historic extremes reminiscent of the… — seekingalpha.com · 06/04 1:58p https://seekingalpha.com/article/4912075-an-irrational-market-8-charts • Fed's Daly says AI is not for now driving inflation up or down San Francisco Federal Reserve President Mary ​Daly on Thursday said ‌that while she believes AI over a five- ​to 10-year window ​could be a deflationary ⁠force, the effect ​is "not a pressing issue" ​for monetary policy which operates on a 12-month horizon. — reuters.com · 06/04 1:47p https://www.reuters.com/business/feds-daly-says-ai-is-not-now-driving-inflation-up-or-down-2026-06-04/

🐘 BIG-CAP MOVERS ON NEWS (≥$10B — the MRVL-class catalysts):

1. SNAP +6% $6.07 (10B cap) Snap Inc. Receives Credit Rating Upgrade from S&P Global Ratings SANTA MONICA, Calif.--(BUSINESS WIRE)--Snap Inc. (NYSE: SNAP) today announced that S&P Global Ratings has upgraded the company's issuer credit rating to BB- from B+, with a positive outlook. S&P also upgraded its issue-level ratings on Snap's unsecured notes to BB- from B+. In i… — businesswire.com · 06/03 5:30p https://www.businesswire.com/news/home/20260603573034/en/Snap-Inc.-Receives-Credit-Rating-Upgrade-from-SP-Global-Ratings/

2. MRVL +5% $316.60 (277B cap) Marvell Technology, Inc. (MRVL) is Attracting Investor Attention: Here is What You Should Know Marvell (MRVL) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock. — zacks.com · 06/04 10:01a https://www.zacks.com/stock/news/2932119/marvell-technology-inc-mrvl-is-attracting-investor-attention-here-is-what-you-should-know?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|most_searched_stocks-2932119

3. NU +4% $12.09 (59B cap) Nu Launches $1 Billion Buyback As Growth Funding Stays Intact Nu Holdings (NU) is giving investors a fresh capital-return signal after its board approved a share repurchase program of up to $1 billion for the company's Cla — gurufocus.com · 06/04 12:14p https://www.gurufocus.com/news/8900933/nu-launches-1-billion-buyback-as-growth-funding-stays-intact

4. NVDA +3% $220.70 (5346B cap) NVIDIA Corporation (NVDA) Presents at Bank of America 2026 Global Technology Conference Transcript NVIDIA Corporation (NVDA) Presents at Bank of America 2026 Global Technology Conference Transcript — seekingalpha.com · 06/04 2:32p https://seekingalpha.com/article/4912081-nvidia-corporation-nvda-presents-at-bank-of-america-2026-global-technology-conference

5. XLF +3% $52.17 (50B cap) Bank Regulators Hope to Sell Congress on Deregulation Bank regulators in the United States are headed to Congress to tout the benefits of deregulation. Their argument is that scaling back banking rules and oversight will spark economic activity without creating more systemic financial risks, Reuters reported Thursday (June 4). — pymnts.com · 06/04 10:30a https://www.pymnts.com/bank-regulation/2026/bank-regulators-hope-sell-congress-deregulation/

6. SOFI +3% $17.11 (22B cap) SoFi vs. Robinhood: Which Is the Better Buy Right Now? Bull Cases, Bear Cases, and a CFP's Verdict — fool.com · 06/04 1:26p https://www.fool.com/investing/2026/06/04/sofi-vs-robinhood-which-is-the-better-buy-right-no/

📈 TOP 12 GAINERS (small/mid-cap % leaders, with catalyst):

1. ABSI +21% $7.20 (1.1B cap) (no fresh news today — likely technical / low-coverage move)

2. ALVO +20% $3.77 (1.2B cap) Alvotech announces resubmission of U.S. Biologics License Applications for AVT05, a proposed biosimilar to Simponi® and Simponi Aria®, and AVT06, a proposed biosimilar to Eylea® REYKJAVIK, Iceland, June 04, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the resubmission to the U.S. Food and Drug Admi… — globenewswire.com · 06/04 4:00a https://www.globenewswire.com/news-release/2026/06/04/3306550/0/en/Alvotech-announces-resubmission-of-U-S-Biologics-License-Applications-for-AVT05-a-proposed-biosimilar-to-Simponi-and-Simponi-Aria-and-AVT06-a-proposed-biosimilar-to-Eylea.html

3. BFLY +19% $5.21 (1.4B cap) (no fresh news today — likely technical / low-coverage move)

4. AGL +18% $97.47 (1.6B cap) These ETFs Owned Russell 2000's Biggest Winners Before They Soared 400%+ In 2026 Investors searching for the biggest stock winners of 2026 may be surprised to learn they already own some of them through small-cap ETFs. — benzinga.com · 06/03 2:54p https://www.benzinga.com/etfs/broad-u-s-equity-etfs/26/06/52984025/these-etfs-owned-russell-2000s-biggest-winners-before-they-soared-400-in-2026

5. SIMAU +17% $15.25 (430M cap) (no fresh news today — likely technical / low-coverage move)

6. IOVA +17% $4.43 (1.6B cap) Iovance's Amtagvi® (lifileucel) Granted Approval for the Treatment of Advanced Melanoma in Australia First T cell therapy for a solid tumor cancer and first treatment option approved in Australia for advanced melanoma after anti-PD-1 and targeted therapy — globenewswire.com · 06/03 4:05p https://www.globenewswire.com/news-release/2026/06/03/3306385/0/en/Iovance-s-Amtagvi-lifileucel-Granted-Approval-for-the-Treatment-of-Advanced-Melanoma-in-Australia.html

7. CURR +17% $3.63 (278M cap) (no fresh news today — likely technical / low-coverage move)

8. LPTH +17% $18.22 (870M cap) (no fresh news today — likely technical / low-coverage move)

9. OSCR +16% $23.84 (6.2B cap) (no fresh news today — likely technical / low-coverage move)

10. BTQ +16% $4.93 (689M cap) (no fresh news today — likely technical / low-coverage move)

11. BOT +16% $33.54 (681M cap) RoboStrategy, Inc. to Host Virtual Investor Presentation on June 10, 2026 NEW YORK, June 04, 2026 (GLOBE NEWSWIRE) -- RoboStrategy, Inc. (Nasdaq: BOT), a registered closed end fund providing exposure to private companies in robotics and physical AI, today announced it will host a Virtual Investor Presentation on June 10, 2026. The company listed on th… — globenewswire.com · 06/04 10:01a https://www.globenewswire.com/news-release/2026/06/04/3306901/0/en/RoboStrategy-Inc-to-Host-Virtual-Investor-Presentation-on-June-10-2026.html

12. ABCL +15% $6.59 (2.0B cap) AbCellera Biologics Bets on Hot Flash Antibody as Pipeline Pivot Gains Steam AbCellera Biologics NASDAQ: ABCL is emphasizing its transition from a partner-based antibody discovery business to a proprietary drug development company, Chief Financial Officer Andrew Booth said during a company presentation focused on the biotech's pipeline and lead clinical… — marketbeat.com · 06/04 1:02p https://www.marketbeat.com/instant-alerts/abcellera-biologics-bets-on-hot-flash-antibody-as-pipeline-pivot-gains-steam-2026-06-04/

— auto-generated, alert-only (not investment advice). 'No fresh news' = likely a technical/low-float move, not a catalyst.